In Vivo Hematopoietic Stem Cell Modification by mRNA Delivery

Researchers developed CD117/LNP–messenger RNA (mRNA), a lipid nanoparticle that encapsulated mRNA and was targeted to the stem cell factor receptor, CD117, on HSCs.